183 related articles for article (PubMed ID: 30254953)
1. Efficacy of Hormonal Therapies for Decreasing Uterine Volume in Patients with Adenomyosis.
Matsushima T; Akira S; Fukami T; Yoneyama K; Takeshita T
Gynecol Minim Invasive Ther; 2018; 7(3):119-123. PubMed ID: 30254953
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of dienogest versus gonadotropin-releasing hormone agonist combined with dienogest sequential therapy in the treatment of adenomyosis].
Zhang HY; Zhu S; Xu W; Wang AQ; Wang XL
Zhonghua Fu Chan Ke Za Zhi; 2022 Nov; 57(11):856-863. PubMed ID: 36456483
[No Abstract] [Full Text] [Related]
3. A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.
Ji M; Yuan M; Jiao X; Li Q; Huang Y; Li J; Wang G
Gynecol Endocrinol; 2022 Feb; 38(2):164-169. PubMed ID: 34749585
[TBL] [Abstract][Full Text] [Related]
4. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest.
Matsushima T; Akira S; Yoneyama K; Takeshita T
Gynecol Endocrinol; 2020 Jun; 36(6):521-524. PubMed ID: 31661345
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the safety of dienogest in women with adenomyosis: A retrospective analysis.
Ono N; Asano R; Nagai K; Sugo Y; Nakamura T; Miyagi E
J Obstet Gynaecol Res; 2021 Apr; 47(4):1433-1440. PubMed ID: 33590656
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice.
Miao J; Lu J; Tang J; Lu P
Gynecol Endocrinol; 2022 Aug; 38(8):656-660. PubMed ID: 35850637
[No Abstract] [Full Text] [Related]
7. Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest.
Takagi H; Takakura M; Sasagawa T
Taiwan J Obstet Gynecol; 2023 Nov; 62(6):852-857. PubMed ID: 38008504
[TBL] [Abstract][Full Text] [Related]
8. Maintenance dienogest therapy following adjuvant gonadotropin-releasing hormone agonist treatment after uterus-sparing surgery in adenomyosis: A retrospective cohort study.
Chan IS; Hsu TF; Shih YC; Chang YH; Wang PH; Chen YJ
Int J Gynaecol Obstet; 2023 Jun; 161(3):751-759. PubMed ID: 36527263
[TBL] [Abstract][Full Text] [Related]
9. Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study.
Uehara M; Wada-Hiraike O; Koga K; Yamamoto N; Hirano M; Harada M; Hirota Y; Osuga Y
Endocr J; 2022 Dec; 69(12):1437-1445. PubMed ID: 36070964
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, Adverse Events, and Challenges of Dienogest in the Management of Symptomatic Adenomyosis: A Comparison with Different Hormonal Treatments.
Kobayashi H
Gynecol Obstet Invest; 2023; 88(2):71-80. PubMed ID: 36682346
[TBL] [Abstract][Full Text] [Related]
11. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
Haiyan S; Lin W; Shuhua H; Wang W
Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
[No Abstract] [Full Text] [Related]
12. Efficacy of combined levonorgestrel-releasing intrauterine system with gonadotropin-releasing hormone analog for the treatment of adenomyosis.
Zhang P; Song K; Li L; Yukuwa K; Kong B
Med Princ Pract; 2013; 22(5):480-3. PubMed ID: 23796720
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
[TBL] [Abstract][Full Text] [Related]
14. High intensity focused ultrasound treatment of adenomyosis: a comparative study.
Guo Q; Xu F; Ding Z; Li P; Wang X; Gao B
Int J Hyperthermia; 2018; 35(1):505-509. PubMed ID: 30306813
[TBL] [Abstract][Full Text] [Related]
15. Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New 'Hit Hard First and then Maintain' Regimen of Administration.
Donnez J; Donnez O; Tourniaire J; Brethous M; Bestel E; Garner E; Charpentier S; Humberstone A; Loumaye E
J Clin Med; 2021 Dec; 10(24):. PubMed ID: 34945090
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the efficacy and safety of dienogest in the treatment of painful symptoms in patients with adenomyosis: a randomized, double-blind, multicenter, placebo-controlled study.
Osuga Y; Fujimoto-Okabe H; Hagino A
Fertil Steril; 2017 Oct; 108(4):673-678. PubMed ID: 28911934
[TBL] [Abstract][Full Text] [Related]
17. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.
Fawzy M; Mesbah Y
Arch Gynecol Obstet; 2015 Dec; 292(6):1267-71. PubMed ID: 25990480
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of human heat shock protein 70 in the endometria and pathological lesions of women with adenomyosis and uterine myoma after GnRH agonist therapy.
Khan KN; Kitajima M; Hiraki K; Fujishita A; Nakashima M; Masuzaki H
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():6-13. PubMed ID: 25697974
[TBL] [Abstract][Full Text] [Related]
19. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
Muraoka A; Osuka S; Yabuki A; Bayasula ; Yoshihara M; Tanaka H; Sonehara R; Miyake N; Murakami M; Yoshita S; Nakanishi N; Nakamura T; Goto M; Iwase A; Kajiyama H
Reprod Biol Endocrinol; 2021 Dec; 19(1):179. PubMed ID: 34872568
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
